← FDA Drug Approvals (Drugs@FDA)

NOCDURNA

NDA · New Drug Application · Sponsor: FERRING PHARMS INC · Approved 2018-06-21

Drug application

FDA Application #

NDA022517

Application type

New Drug Application

Brand name

NOCDURNA

Generic name

Desmopressin Acetate

Active ingredients

DESMOPRESSIN ACETATE

Dosage form

TABLET

Route

SUBLINGUAL

Marketing status

Discontinued

Sponsor

FERRING PHARMS INC

First approval

2018-06-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown